标题
Dual targeting strategies with bispecific antibodies
作者
关键词
-
出版物
mAbs
Volume 4, Issue 2, Pages 182-197
出版商
Informa UK Limited
发表日期
2012-03-13
DOI
10.4161/mabs.4.2.19000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains
- (2011) Jürgen Schanzer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emerging therapies for severe asthma
- (2011) Neil C Thomson et al. BMC Medicine
- The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone
- (2011) Joseph M. Tuscano et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor
- (2011) Niels Jørgen Østergaard Skartved et al. CLINICAL CANCER RESEARCH
- A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
- (2011) S. M. Rudman et al. CLINICAL CANCER RESEARCH
- Therapeutic potential of anticancer immunotoxins
- (2011) Swati Choudhary et al. DRUG DISCOVERY TODAY
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging antibody combinations in oncology
- (2011) Stephen J. Demarest et al. mAbs
- A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity
- (2011) Jianying Dong et al. mAbs
- A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor
- (2011) Stuart L. Emanuel et al. mAbs
- A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting
- (2011) Ingo Schubert et al. mAbs
- Antibody-based therapeutics to watch in 2011
- (2011) Janice M. Reichert mAbs
- Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
- (2011) Sònia Tugues et al. MOLECULAR ASPECTS OF MEDICINE
- Recombinant proteins in rheumatology – recent advances
- (2011) Achim Rothe et al. New Biotechnology
- Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes
- (2011) M. Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
- (2011) W. Schaefer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins
- (2011) B.-J. Laventie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
- (2011) Maurie Markman Cancer Management and Research
- Targeting the B Cell in Rheumatoid Arthritis
- (2010) Stanley B. Cohen BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Bispecific Antibodies for Cancer Immunotherapy
- (2010) Dafne Müller et al. BIODRUGS
- Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias
- (2010) P. Gupta et al. BLOOD
- A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting
- (2010) Markus Kügler et al. BRITISH JOURNAL OF HAEMATOLOGY
- A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin
- (2010) Geng Kou et al. CANCER LETTERS
- MM-111: a novel bispecific antibody targeting ErbB3 with potent anti-tumor activity in ErbB2 over-expressing malignancies.
- (2010) U Nielsen et al. CANCER RESEARCH
- A Bispecific Antibody-IFN 2b Immunocytokine Targeting CD20 and HLA-DR Is Highly Toxic to Human Lymphoma and Multiple Myeloma Cells
- (2010) E. A. Rossi et al. CANCER RESEARCH
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
- (2010) Diane Seimetz et al. CANCER TREATMENT REVIEWS
- Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2
- (2010) Xiao-Feng Le et al. CELL CYCLE
- A bispecific nanobody to provide full protection against lethal scorpion envenoming
- (2010) Issam Hmila et al. FASEB JOURNAL
- Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity
- (2010) Jianying Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling
- (2010) Janet Jackman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
- (2010) Kannan Gunasekaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion
- (2010) Syd Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature
- (2010) Alexander K. Tsai et al. JOURNAL OF NEURO-ONCOLOGY
- Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
- (2010) Jennifer S. Michaelson et al. mAbs
- Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-IgTM) molecules
- (2010) Chengbin Wu et al. mAbs
- A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo
- (2010) Robert Mabry et al. mAbs
- Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
- (2010) J. Dong et al. MOLECULAR CANCER THERAPEUTICS
- Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases
- (2010) D. A. Vallera et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes
- (2010) Shuyan Meng et al. NANOTECHNOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- A New Drug Delivery Method of Bispecific Ligand-Directed Toxins, Which Reduces Toxicity and Promotes Efficacy in a Model of Orthotopic Pancreatic Cancer
- (2010) Seunguk Oh et al. PANCREAS
- Chemical generation of bispecific antibodies
- (2010) V. R. Doppalapudi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties
- (2010) G. Wozniak-Knopp et al. PROTEIN ENGINEERING DESIGN & SELECTION
- SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies†
- (2010) Jonathan H. Davis et al. PROTEIN ENGINEERING DESIGN & SELECTION
- High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
- (2009) V. Ludovini et al. ANNALS OF ONCOLOGY
- Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
- (2009) Roland E. Kontermann BIODRUGS
- Engineering and characterization of a bispecific HER2 × EGFR-binding affibody molecule
- (2009) Mikaela Friedman et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
- (2009) E. A. Rossi et al. BLOOD
- Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity
- (2009) B J Stish et al. BRITISH JOURNAL OF CANCER
- A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy
- (2009) Yuki Murase et al. CANCER LETTERS
- A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma
- (2009) S. Oh et al. CLINICAL CANCER RESEARCH
- Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
- (2009) J. Veeken et al. CURRENT CANCER DRUG TARGETS
- Denileukin diftitox: a novel immunotoxin
- (2009) George Manoukian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- DARPins as Bispecific Receptor Antagonists Analyzed for Immunoglobulin E Receptor Blockage
- (2009) Alexander Eggel et al. JOURNAL OF MOLECULAR BIOLOGY
- Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery
- (2009) Seunguk Oh et al. JOURNAL OF NEURO-ONCOLOGY
- Bispecific immunotoxins
- (2009) Arthur E. Frankel et al. LEUKEMIA RESEARCH
- Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy
- (2009) Daniel A. Vallera et al. LEUKEMIA RESEARCH
- Synergistic Targeting of αvβ3Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis
- (2009) Ewelina Kluza et al. NANO LETTERS
- Dual targeting of a thermosensitive nanogel conjugated with transferrin and RGD-containing peptide for effective cell uptake and drug release
- (2009) Chang-Yun Quan et al. NANOTECHNOLOGY
- Engineering of stable bispecific antibodies targeting IL-17A and IL-23
- (2009) Robert Mabry et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A modular IgG-scFv bispecific antibody topology
- (2009) Kelly Davis Orcutt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Monoclonal antibody-based therapies for microbial diseases
- (2009) Carolyn Saylor et al. VACCINE
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Durable complete responses from therapy with combined epratuzumab and rituximab
- (2008) John P. Leonard et al. CANCER
- The epidermal growth factor receptor family: Biology driving targeted therapeutics
- (2008) M. J. Wieduwilt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Molecular engineering and design of therapeutic antibodies
- (2008) Leonard G Presta CURRENT OPINION IN IMMUNOLOGY
- Antibody–cytokine fusion proteins: applications in cancer therapy
- (2008) Elizabeth Ortiz-Sánchez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody-modified liposomes for cancer chemotherapy
- (2008) Vladimir Torchilin Expert Opinion on Drug Delivery
- Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
- (2008) D. A. Vallera et al. GUT
- Th17 Cell Differentiation: The Long and Winding Road
- (2008) Mandy J. McGeachy et al. IMMUNITY
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells
- (2008) Christian Kellner et al. JOURNAL OF IMMUNOTHERAPY
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification
- (2005) David F. Nellis et al. BIOTECHNOLOGY PROGRESS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started